...
首页> 外文期刊>Journal of International Medical Research >Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis
【24h】

Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis

机译:基于老年患者心血管结果的西汀毒素治疗的疗效:标准荟萃分析和贝叶斯网络分析

获取原文
           

摘要

Objective Statins have been shown to be beneficial for the prevention of cardiovascular events. In elderly individuals, the efficacy of statins remains controversial and the comparative effect of statins has not been assessed. Methods MEDLINE, Embase, and the Cochrane Central database were searched for randomized controlled trials that assessed statins in older patients. Results Seventeen trials were analyzed. When used for secondary prevention, statins were associated with reduced risk of cardiovascular events, all-cause mortality, cardiovascular mortality, revascularization, and stroke. When used for primary prevention, statins reduced the risk of myocardial infarction and revascularization, but did not significantly affect other outcomes. A modest difference between pharmaceutical statin products was found, and high-quality evidence indicated that intensive atorvastatin had the greatest benefits for secondary prevention. Conclusions In secondary prevention, evidence strongly suggests that statins are associated with a reduction in the risk of all-cause mortality, cardiovascular events, cardiovascular mortality, and revascularization. However, differences in the effects of various statins do not appear to have significant effects on therapy in secondary prevention for the elderly.
机译:目的他汀类药物已被证明对预防心血管事件有益。在老年人身上,他汀类药物的疗效仍然存在争议,并且尚未评估他汀类药物的比较效应。方法搜索Medline,Embase和Cochrane Central数据库,用于评估老年患者他汀类药物的随机对照试验。结果分析了十七次试验。当用于二次预防时,他汀类药物与心血管事件的风险降低,全导致死亡率,心血管死亡率,血运重建和中风有关。当用于预防初步时,他汀类药物降低了心肌梗死和血运重建的风险,但没有显着影响其他结果。发现药物汀类药物的适度差异,高质量的证据表明,密集的阿托伐他汀对二级预防具有最大的益处。结论中的二级预防,证据强烈表明他汀类药物与患有全因死亡率,心血管事件,心血管死亡率和血流性的风险的降低有关。然而,各种毒素的影响的差异似乎对老年人的二级预防治疗没有显着影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号